Glasdegib Plus Intensive/Nonintensive Chemotherapy in Untreated Acute Myeloid Leukemia: BRIGHT AML 1019 Phase III Trials
2019 · Future Oncology · 48 citations
https://doi.org/10.2217/fon-2019-0373
T
Tetsuzo Tauchi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
240
Papers
4.4K
Citations
36
h-index
94
i10-index
Tetsuzo Tauchi is an academic researcher from Shioda General Hospital. The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research & Acute Myeloid Leukemia Research. The author has an h-index of 36, co-authored 204 publications.
Papers by this author
worksDasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line
2011 · Journal of Hematology & Oncology · 20 citations
https://doi.org/10.1186/1756-8722-4-32
Combined effects of the hedgehog pathway inhibitor LDE225 and nilotinib in a random mutagenesis screen
2012 · Arthritis Research & Therapy · 0 citations
https://doi.org/10.1186/ar3598
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat